These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Incidence and correlates of tardive dyskinesia in first episode of schizophrenia. Chakos MH; Alvir JM; Woerner MG; Koreen A; Geisler S; Mayerhoff D; Sobel S; Kane JM; Borenstein M; Lieberman JA Arch Gen Psychiatry; 1996 Apr; 53(4):313-9. PubMed ID: 8634009 [TBL] [Abstract][Full Text] [Related]
24. Preventing neuroleptic-induced tardive dyskinesia in adults and children. Lam RW; Jeste SD; Jeste DV Encephale; 1988 Sep; 14 Spec No():251-5. PubMed ID: 2905652 [TBL] [Abstract][Full Text] [Related]
25. The role of parkinsonism and antiparkinsonian therapy in the subsequent development of tardive dyskinesia. Elliott KJ; Lewis S; el-Mallakh RS; Looney SW; Caudill R; Bacani-Oropilla T Ann Clin Psychiatry; 1994 Sep; 6(3):197-203. PubMed ID: 7881501 [TBL] [Abstract][Full Text] [Related]
27. A summary of current knowledge of tardive dyskinesia. Baldessarini RJ Encephale; 1988 Sep; 14 Spec No():263-8. PubMed ID: 2905654 [TBL] [Abstract][Full Text] [Related]
28. The natural history of tardive dyskinesia. Gardos G; Cole JO; Haskell D; Marby D; Paine SS; Moore P J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):31S-37S. PubMed ID: 2906068 [TBL] [Abstract][Full Text] [Related]
29. Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications. Glazer WM; Morgenstern H; Doucette JT J Clin Psychiatry; 1993 Apr; 54(4):133-9. PubMed ID: 8098030 [TBL] [Abstract][Full Text] [Related]
30. Tardive dyskinesia: prevalence, incidence, and risk factors. Kane JM; Woerner M; Lieberman J Psychopharmacology Suppl; 1985; 2():72-8. PubMed ID: 2860662 [TBL] [Abstract][Full Text] [Related]
31. Tardive dyskinesia: a five year follow-up. Fornazzari X; Grossman H; Thornton J; Seeman MV Can J Psychiatry; 1989 Oct; 34(7):700-3. PubMed ID: 2572317 [TBL] [Abstract][Full Text] [Related]
32. The effect of neuroleptics and tardive dyskinesia on smooth-pursuit eye movement in chronic schizophrenics. Spohn HE; Coyne L; Spray J Arch Gen Psychiatry; 1988 Sep; 45(9):833-40. PubMed ID: 2901252 [TBL] [Abstract][Full Text] [Related]
33. Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curaçao Extrapyramidal Syndromes Study III. van Harten PN; Hoek HW; Matroos GE; Koeter M; Kahn RS Am J Psychiatry; 1998 Apr; 155(4):565-7. PubMed ID: 9546009 [TBL] [Abstract][Full Text] [Related]
36. The changing effector pattern of tardive dyskinesia during the course of neuroleptic withdrawal. Newell KM; Wszola B; Sprague RL; Mahorney SL; Bodfish JW Exp Clin Psychopharmacol; 2001 Aug; 9(3):262-8. PubMed ID: 11534536 [TBL] [Abstract][Full Text] [Related]
37. Tardive dyskinesia in northern Israel: preliminary study. Schwartz M; Silver H; Tal I; Sharf B Eur Neurol; 1993; 33(3):264-6. PubMed ID: 8096816 [TBL] [Abstract][Full Text] [Related]
38. Tardive dyskinesia in older out-patients: a follow-up study. Labbate LA; Lande RG; Jones F; Oleshansky MA Acta Psychiatr Scand; 1997 Sep; 96(3):195-8. PubMed ID: 9296550 [TBL] [Abstract][Full Text] [Related]
39. Early extrapyramidal side-effects as risk factors for later tardive dyskinesia: a prospective study. Sachdev P Aust N Z J Psychiatry; 2004 Jun; 38(6):445-9. PubMed ID: 15209837 [TBL] [Abstract][Full Text] [Related]
40. New strategies for old problems: tardive dyskinesia (TD). Review and report on severe TD cases treated with clozapine, with 12, 8 and 5 years of video follow-up. Larach VW; Zamboni RT; Mancini HR; Mancini RR; Gallardo RT Schizophr Res; 1997 Dec; 28(2-3):231-46. PubMed ID: 9468357 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]